AIFarm, Ltd.
AIFM · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $10 | $29 |
| Gross Profit | $0 | $0 | -$10 | -$29 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $487 | $85 | $608 | $1,228 |
| SG&A Expenses | $487 | $85 | $608 | $1,712 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $484 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $487 | $85 | $608 | $1,748 |
| Operating Income | -$487 | -$85 | -$608 | -$1,748 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$60 | -$25 | $671 | -$22 |
| Pre-Tax Income | -$547 | -$111 | $63 | -$1,770 |
| Tax Expense | $0 | -$1 | $0 | -$150 |
| Net Income | -$547 | -$110 | $54 | -$1,620 |
| % Margin | – | – | – | – |
| EPS | -0.97 | -0.3 | 0.002 | -0.076 |
| % Growth | -223.3% | -12,600% | 103.2% | – |
| EPS Diluted | -0.97 | -0.3 | 0.002 | -0.076 |
| Weighted Avg Shares Out | 562 | 369 | 22,396 | 21,278 |
| Weighted Avg Shares Out Dil | 562 | 369 | 22,396 | 21,278 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $8 | $22 |
| Depreciation & Amortization | $487 | $10 | $10 | $29 |
| EBITDA | -$60 | -$111 | $82 | -$1,719 |
| % Margin | – | – | – | – |